
Hepatocellular carcinoma is the most common type of liver cancer. It is an aggressive (fast-growing) cancer that most commonly affects persons with severe liver disease, such as cirrhosis. People with HCC are increasingly being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), which can develop to cirrhosis.
Early treatment of Hepatocellular Carcinoma (HCC) is essential for improving patient outcomes and survival rates. Early discovery enables more effective treatment choices, such as surgical resection, liver transplantation, or local therapy (e.g., ablation or embolisation), which may cure the cancer or considerably postpone its progression. Delaying treatment can cause tumour growth, spread (metastasis), and poor liver function, making cancer more difficult to cure and decreasing the likelihood of a favourable outcome. Early intervention also enhances quality of life by enabling more effective symptom management.
Tumours may not present symptoms in their early stages. However, as HCC proceeds, you may notice:
Causes
Risk Factors
The following conditions enhance your risk of developing HCC:
There are various ways to lower your chance of having HCC. You can do:
Treatments include:
Surgery: The surgical treatments for HCC are hepatectomy (removal of the diseased section of the liver) or liver transplantation.
Cost Start From USD 25000 - USD 35000Explore Options
Ablation therapy: This involves the use of a specialised needle to burn malignancies. The needle can direct highly hot energy (microwaves or radiofrequency waves) or extremely cold.
Embolisation: It is the process of implanting a material directly into the arteries that supply the tumour, blocking blood flow.
Radiation therapy: Providers may recommend radiation therapy to treat tiny cancers that cannot be removed surgically or destroyed through ablation.
Immunotherapy: Immunotherapy drugs are also used to treat advanced HCC. They help your immune system recognise and combat cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Targeted therapy: These medications treat advanced HCC. This medication inhibits the signal that tells cancer cells to continue growing.
Cost Start From USD 8000 - USD 12000Explore Options
The following tests can assist in confirming a diagnosis:
Rehabilitation treatments for Hepatocellular Carcinoma (HCC) are aimed at increasing quality of life, accelerating physical recovery, and minimising therapeutic side effects. Here are the main rehabilitation alternatives for HCC patients:
Physical Rehabilitation: After liver surgery or transplant, patients may receive physical therapy to restore strength, increase flexibility, and minimise fatigue. A personalised workout regimen might help you improve your overall fitness and stamina.
Mobility assistance: Patients with limited movement due to treatment side effects may benefit from exercises to enhance balance and coordination.
Psychosocial support: Therapy or joining a support group can help cancer patients deal with the emotional and mental challenges of their treatment.
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Delhi, India
BLK-Max Super Speciality Hospital, located in New Delhi, is the leading best-in-class healthcare institution in India, providing tertiary and quaternary care. 650 + beds including 162 critical care beds, 22 OTs with 1,500+ clinical professionals allied to health are at the hospital's disposal. JCI, NABH, and NABL accredited. The hospitals are a leader in transplants, cancer care, and robotic surgery education and implementation. Established in1959 by Dr. B.L. Kapur, the hospital combines state-of-the-art technology with patient-centric values including compassion, efficiency, and consistency.

Mumbai, India
Fortis Hospital Mulund, located in Mulund West, Mumbai, is a premier healthcare facility providing excellence in multi-speciality healthcare for over 20 years. The global leader in advancing medical technology and clinical expertise, the hospital offers specialities including Cardiology, Neurosciences, Oncology, Transplants, and Orthopaedics. The hospital is well-known for being the largest transplant center in Maharashtra and offers advanced treatment options, including Transcatheter Aortic Valve Implantation (TAVI) and stereotactic precision radiotherapy for cancer. Fortis Mulund is equipped with a 24/7 Emergency Department and International Patient Unit to provide world-class patient-centric care.

Delhi, India
Max Smart Super Speciality Hospital, Saket, is a 250-bed tertiary care hospital awarded NABH accreditation, which provides advanced medical care in various specialities such as Cardiac Sciences, Orthopaedics, Neurology, Urology, Kidney Transplant, Paediatrics, and Obstetrics & Gynaecology. The hospital provides quality, safe, integrated, and patient-centric medical care using modular OTs, ICUs, Cath Labs, CT, MRI and Dialysis units.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing India:
Yes, liver transplantation is a possibility for patients with early-stage HCC, mainly if the tumour is localised to the liver and the patient has cirrhosis. India has several transplant centres that provide this procedure.
Early diagnosis and treatment increase the chance of survival. Surgical resection or liver transplantation can provide a cure in the early stages, while modern therapies such as targeted medicines and immunotherapy can enhance quality of life and increase survival.
Survival rates vary depending on the stage of diagnosis. Early-stage HCC treated with surgery or liver transplantation has a much greater survival rate; however, advanced cases may have a poorer survival rate despite treatment. Early diagnosis and treatment significantly enhance outcomes.
Yes, lifestyle changes include:
HCC is one of the most common malignancies in India, particularly in areas with a high prevalence of hepatitis B and C infections. However, its prevalence is on the rise as non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver damage become more common.
Many patients can retain a high quality of life thanks to improved treatments such as surgery, liver transplants, and tailored medications. However, the disease's impact varies depending on the stage of cancer and the available treatment options.